But at $67.27, This Once-Screaming Bargain Now Just Gently Hums "Value-ish" 🎶

As of July 18, 2025 — BN closed at $67.27 📉 (-1.28%), but let’s be real: Bill Ackman is still smiling. 🏛️ 

🧠 Quick Recap: Bill Ackman’s Top Holdings (Q1 2025)

🛡️ Why Ackman Still Loves Brookfield

• 📉 The huge discount has vanished… but the fundamentals still flex 💪

• 🧑 Insiders own 17.5% — they're not just passengers, they're copilots 🛫

• 🐻 Short interest is a featherweight (1.17%) — even the bears are bored.
  

🏦 Institutional Investors Aren’t Out Either:

🧊 70.33% of float is held by institutions. No mass exodus here.

🔍 For Institutional Ownership breakdown, see here. 

💵 Brookfield’s Financial Firepower

✅ Distributable Earnings (Q1 2025):

• $1.5B total

• $0.98/share

• +30% YoY 💥

✅ Deployable Capital:

• $165 billion 😲

• $69B in cash, financial assets, or undrawn credit lines

• Enough to buy… like… a small country 🌍

✅ Q1 2025 Share Buybacks:

• $850M worth of shares repurchased (📉 supply, 📈 value per share)

✅ Dividend:

• $0.09/quarter (modest, but steady 💌)

🏗️ Business Breakdown (Q1 2025):

• 🏦 Asset Management:
  $684M in DE | $698M in fee earnings | $25B in inflows
  ➕ Closed $16B flagship credit fund
  ➕ Acquired Angel Oak (💸 $18B AUM)

• 💰 Wealth Solutions:
  $430M in DE | Insurance assets at $133B
  ➕ Raising ~$2B/month in retail capital
  ➕ 15% ROIC on $11.5B invested capital
  ➕ Yield = 5.7% vs. cost of funds = 3.9% 🧃

• 🏢 Operating Businesses:
  $426M in DE | $1.7B LTM
  ➕ 3% NOI growth on real estate
  ➕ 9M sq ft of leases signed
  ➕ $640M proceeds from housing sales

• 📉 2024 Financials Recap:

  • $4.9B in DE (record)

  • $135B in inflows

  • $1B in buybacks

  • Dividend raised 13% 💸

👉 Want the full picture? Dive into Brookfield Corporation's financials here.

📊 Brookfield’s Stock Price: Now What?

🔺 Up nearly 50% in just over 3 months
📍Current: $67.27
📈 ATH: $68.75
💰 Forward P/E: 23.64 (vs. 16.23 last year)
📦 Price/Sales: 1.32 (was 0.69)
📘 Price/Book: 2.51 (was 1.55)
🚂 EV/Revenue: 4.20 (was 3.01)

🎯 Our Take

🔥 The Bull Case:

• 🏋️♂️ Strong DE, real earnings, no meme-y nonsense

• 💵 Huge buybacks + real returns = shareholder love

• 🧠 Ackman’s conviction = confidence booster

• 🛠️ Real assets, global reach, and a mountain of dry powder

🧊 The Not-So-Hot Case:

• 📉 Total revenue has been slowly declining
  From $95.9B (2023) → $86.0B (2024) → $81.0B (TTM)

• 📉 Net income declining too
  From $1.13B → $641M → $612M

• ⚠️ Valuation no longer screams “steal!”

• 🧗 Stock is hugging all-time highs — correction risk is real

💡💡💡 Curious about another deep oil exploration play?
Check our takes on UnitedHealth Group or even Oscar Health.

🕵️♂️ Final Word

Brookfield is still a powerhouse, but the easy money may be gone. If you're looking for growth at a reasonable price (a.k.a. GARP 🎩), you might want to wait for a dip — or at least buckle up before you board. ✈️

🚨 Disclaimer:

This is not financial advice. It’s just a second opinion — and yes, we’re billing your sense of humor. 🎪💸

We know nothing and no one. Invest at your own risk. Or blame Bill Ackman if things go sideways. Just kidding. Sort of. 😉

🧭 Want More Like This?

• 🕵️ Insider Purchases Center
• 📣 Follow the Pundits Hub
• 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
• 😆 Stock Market Humor & Serious-ish Plays
• 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
• 🧟 Corporate Resurrection Series — Our special series on companies rising from the financial grave. 🎯 The “Turnaround or Toast” Series (If it still exists. We’re not sure. Ask the intern.)
• 📈 Biotech Bets & Innovation Radar (Problem is we can't detect the Radar)

😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny